The therapeutic development of Scleroderma is burgeoning with immense business potential

100 %
0 %
Information about The therapeutic development of Scleroderma is burgeoning with immense...
Business & Mgmt

Published on March 7, 2014

Author: researchonglobalmarkets

Source: slideshare.net

Description

For the complete report ,visit us at: http://bit.ly/systemic-sclerosis-2013

Or, get in touch with us at : support@researchonglobalmarkets.com

Abstract:
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013
Summary
Global Markets Directs, 'Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Sclerosis (Scleroderma). Systemic Sclerosis (Scleroderma) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Systemic Sclerosis (Scleroderma).
- A review of the Systemic Sclerosis (Scleroderma) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.

Table of Contents:
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Systemic Sclerosis (Scleroderma) Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Systemic Sclerosis (Scleroderma) 9
Systemic Sclerosis (Scleroderma) Therapeutics under Development by Companies 11
Systemic Sclerosis (Scleroderma) Therapeutics under Investigation by Universities/Institutes 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Discovery and Pre-Clinical Stage Products 16
Comparative Analysis 16
Systemic Sclerosis (Scleroderma) Therapeutics - Products under Development by Companies 17
Systemic Sclerosis (Scleroderma) Therapeutics - Products under Investigation by Universities/Institutes 18
Companies Involved in Systemic Sclerosis (Scleroderma) Therapeutics Development 19
Genzyme Corporation 19
F. Hoffmann-La Roche Ltd. 20
Sanofi-Aventis 21
GlaxoSmithKline plc 22

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Category: Healthcare Insert Image Height - 3.60 Width – 4.98 www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Coverage • A snapshot of the global therapeutic scenario for Systemic Sclerosis (Scleroderma) • A review of the Scleroderma products under development by companies and universities or research institutes based on information derived from company and industry-specific sources • Coverage of products based on various stages of development ranging from discovery till registration stages • A feature on pipeline projects on the basis of monotherapy and combined therapeutics • Coverage of the Scleroderma pipeline on the basis of route of administration and molecule type www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Coverage (Continued) • All discontinued pipeline projects • Latest news and deals related to the products www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Benefits • Identify and understand diverse types of therapeutics under development for Scleroderma • Identify emerging players with potentially strong product portfolio • Design effective counter-strategies to gain competitive advantage • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Scleroderma pipeline depth and focus of indication therapeutics • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Benefits (Continued) • Modify your therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Table of Contents • Introduction • Overview • Comparative Analysis • R&D Progress • Appendix • Methodology www.researchonglobalmarkets.com

Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 Report Details • • • • • • • • • Publish date: 29th Oct, 2013 Number of slides: 87 Geographic coverage: Global Available format: PDF, CD, Hardcopy Price for Single User License: USD 2,000 Price for Site License: USD 4,000 Price for Global User License: USD 6,000 Delivery Time: Within 1 business day Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal www.researchonglobalmarkets.com

Interested in this report? To view more details regarding this premium market research report, Please click here For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports Industry Segments Automotive & Transport Consumer goods Agriculture Food and Beverage Energy and Utilities Public Sector Manufacturing & Construction Healthcare Media & Entertainment IT, Telecom & Electronics Services Others www.researchonglobalmarkets.com

Add a comment

Related presentations

Related pages

The therapeutic development of Scleroderma is burgeoning ...

... The therapeutic development of Scleroderma is burgeoning with immense business potential, ... the Scleroderma products under development by ...
Read more

The therapeutic development of Scleroderma is burgeoning ...

... The therapeutic development of Scleroderma is burgeoning with immense business potential, ... Home & Garden Business Travel Education Sports ...
Read more

Market Research Reports – Business Information, Consulting ...

The global superhydrophobic coatings market is characterized by high capital investment and immense ... potential for growth, given ... this burgeoning ...
Read more

Medical Devices Business Trends & Latest ... - BioMedTrends

Medical Devices Business Trends & Latest Market Research: Angiogenesis Inhibitors and Stimulators.
Read more

Archive News & Video for Tuesday, 10 Jun 2014 | Reuters.com

Site Archive for Tuesday, 10 Jun 2014. ... Demonstrate Therapeutic Advantages Of The Boston Scientific ... Of Worldwide Sales And Business Development; ...
Read more

Full text of "Report on the activity of the Committee on ...

Full text of "Report on the activity of the Committee on Energy and Commerce for the ... Congress" See other formats ...
Read more

Machine Learning @ Johns Hopkins University | Talks

Machine Learning @ Johns Hopkins University. Home; ... a critical role in the development and function of both ... realize the potential of ...
Read more

Книжный интернет магазин www.logobook.ru

... current status and future potential of English ... It was an immense oversight for emotions ... and explore promising areas of therapeutic development.
Read more

medical Business Trends & Latest Market ... - BioMedTrends

... evaluating its business potential in seven key ... pemphigus, and scleroderma. ... potential opportunity for the development of therapeutic ...
Read more